JG
ELOS

Jefferies Group’s Syneron Medical Ltd ELOS Stock Holding History

Jefferies Group’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-246,800
Closed -$2.7M – 2796
2017
Q2 		$2.7M Buy
+246,800
New +$2.71M 0.02% 809
2015
Q3 		– Sell
-91,734
Closed -$974K – 3545
2015
Q2 		$974K Buy
+91,734
New +$1.07M 0.01% 1246

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Jefferies Group's ELOS Position: Q3 2017 in Review

Jefferies Group sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 246,800 shares — an estimated $2.7M sold.

Jefferies Group first reported a position in ELOS in Q2 2015 and held it in 2 quarters. The position peaked at $2.7M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Jefferies Group reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Jefferies Group sold 246,800 Syneron Medical Ltd shares in Q3 2017, an estimated $2.7M.
  • Jefferies Group first reported a position in Syneron Medical Ltd in Q2 2015 and held it in 2 quarters.
  • Jefferies Group's Syneron Medical Ltd position peaked at $2.7M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Jefferies Group's 13F filing for Q3 2017, filed 14 Nov 2017.